Nadia Hidri

964 total citations
19 papers, 738 citations indexed

About

Nadia Hidri is a scholar working on Infectious Diseases, Molecular Medicine and Clinical Biochemistry. According to data from OpenAlex, Nadia Hidri has authored 19 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Medicine and 5 papers in Clinical Biochemistry. Recurrent topics in Nadia Hidri's work include Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Nadia Hidri is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Nadia Hidri collaborates with scholars based in France and Poland. Nadia Hidri's co-authors include Marie‐Laure Joly‐Guillou, Guilène Barnaud, Matthieu Eveillard, Guillaume Arlet, Y Boussougant, Charlotte Verdet, Valérie Gautier, Zahia Ould-Hocine, Catherine Eckert and A. Philippon and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Nadia Hidri

19 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia Hidri France 12 345 314 180 175 157 19 738
Andrew N. Ginn Australia 16 392 1.1× 204 0.6× 167 0.9× 190 1.1× 201 1.3× 38 917
A. Florijn Netherlands 11 365 1.1× 200 0.6× 137 0.8× 143 0.8× 200 1.3× 12 665
Tracie Lloyd Canada 13 295 0.9× 199 0.6× 226 1.3× 106 0.6× 176 1.1× 21 717
Annette Jurke Germany 13 274 0.8× 366 1.2× 120 0.7× 208 1.2× 109 0.7× 26 761
Adriana Belas Portugal 15 323 0.9× 208 0.7× 157 0.9× 220 1.3× 119 0.8× 30 703
Françoise Chau France 18 346 1.0× 330 1.1× 112 0.6× 214 1.2× 314 2.0× 46 912
Najiby Kassis‐Chikhani France 11 652 1.9× 191 0.6× 287 1.6× 189 1.1× 215 1.4× 17 923
Dorota Jamrozy United Kingdom 19 486 1.4× 289 0.9× 200 1.1× 258 1.5× 189 1.2× 41 943
Claire Perry United Kingdom 16 561 1.6× 226 0.7× 338 1.9× 251 1.4× 159 1.0× 23 885
Deborah Gascoyne‐Binzi United Kingdom 16 347 1.0× 334 1.1× 187 1.0× 169 1.0× 367 2.3× 25 891

Countries citing papers authored by Nadia Hidri

Since Specialization
Citations

This map shows the geographic impact of Nadia Hidri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Hidri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Hidri more than expected).

Fields of papers citing papers by Nadia Hidri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Hidri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Hidri. The network helps show where Nadia Hidri may publish in the future.

Co-authorship network of co-authors of Nadia Hidri

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Hidri. A scholar is included among the top collaborators of Nadia Hidri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Hidri. Nadia Hidri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hidri, Nadia, et al.. (2015). Moraxella osloensis, an emerging pathogen of endocarditis in immunocompromised patients?. Swiss Medical Weekly. 145(3738). w14185–w14185. 19 indexed citations
2.
Hidri, Nadia, Olivier Barraud, S. De Martino, et al.. (2012). Lyme endocarditis. Clinical Microbiology and Infection. 18(12). E531–E532. 21 indexed citations
3.
Barraud, Olivier, Nadia Hidri, K.H. Ly, et al.. (2012). Pacemaker-associated Bacillus cereus endocarditis. Diagnostic Microbiology and Infectious Disease. 74(3). 313–315. 13 indexed citations
4.
Hidri, Nadia. (2012). Identification d’Acinetobacter spp. au laboratoire. Revue Francophone des Laboratoires. 2012(441). 37–42. 1 indexed citations
5.
Denes, É., Nadia Hidri, Marie-Cécile Ploy, et al.. (2011). Infection d’hématome sous-dural chronique à Campylobacter fetus : à propos d’un cas. Neurochirurgie. 58(1). 52–54. 9 indexed citations
6.
Denes, É. & Nadia Hidri. (2009). Synergie et antagonisme en antibiothérapie. INRIA a CCSD electronic archive server. 11(2). 106–115. 10 indexed citations
7.
Verdet, Charlotte, Valérie Gautier, Élisabeth Chachaty, et al.. (2009). Genetic Context of Plasmid-CarriedblaCMY-2-Like Genes inEnterobacteriaceae. Antimicrobial Agents and Chemotherapy. 53(9). 4002–4006. 51 indexed citations
8.
Hidri, Nadia, Claudio Farina, Bogumiła Szponar, et al.. (2008). <i>Nocardia</i> i nokardiozy. 69(11-12). 677–1363. 1 indexed citations
9.
Ricard, Jean-Damien, Michel Wolff, Jean-Claude Lachérade, et al.. (2006). Levels of Vancomycin in Cerebrospinal Fluid of Adult Patients Receiving Adjunctive Corticosteroids to Treat Pneumococcal Meningitis: A Prospective Multicenter Observational Study. Clinical Infectious Diseases. 44(2). 250–255. 82 indexed citations
10.
Eveillard, Matthieu, et al.. (2005). Estimation of methicillin-resistant Staphylococcus aureus transmission by considering colonization pressure at the time of hospital admission. Journal of Hospital Infection. 60(1). 27–31. 26 indexed citations
11.
Hidri, Nadia, Guilène Barnaud, Dominique Decré, et al.. (2005). Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC β-lactamase of a Serratia marcescens clinical isolate. Journal of Antimicrobial Chemotherapy. 55(4). 496–499. 20 indexed citations
12.
Lassence, Arnaud de, Nadia Hidri, Marie‐Laure Joly‐Guillou, et al.. (2005). Control and Outcome of a Large Outbreak of Colonization and Infection with Glycopeptide-Intermediate Staphylococcus aureus in an Intensive Care Unit. Clinical Infectious Diseases. 42(2). 170–178. 52 indexed citations
13.
Barnaud, Guilène, et al.. (2005). Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure. Journal of Hospital Infection. 59(3). 254–258. 26 indexed citations
14.
Eveillard, Matthieu, et al.. (2004). Carriage of Methicillin-ResistantStaphylococcus aureusAmong Hospital Employees: Prevalence, Duration, and Transmission to Households. Infection Control and Hospital Epidemiology. 25(2). 114–120. 142 indexed citations
15.
Eckert, Catherine, Valérie Gautier, Nadia Hidri, et al.. (2004). Dissemination of CTX-M-Type β-Lactamases among Clinical Isolates of Enterobacteriaceae in Paris, France. Antimicrobial Agents and Chemotherapy. 48(4). 1249–1255. 236 indexed citations
16.
Lassence, Arnaud de, Marie‐Laure Joly‐Guillou, Laurent Martin‐Lefèvre, et al.. (2004). Accuracy of delayed (24 hours) processing of bronchoalveolar lavage for diagnosing bacterial pneumonia. Critical Care Medicine. 32(3). 680–685. 4 indexed citations
17.
Hidri, Nadia, B. Bruneau, H. Mal, et al.. (2002). [Isolation of three species of Nocardia in a patient receiving long-term corticosteroid therapy].. PubMed. 31(11). 503–4. 3 indexed citations
18.
Hidri, Nadia, Claudio Farina, Bogumiła Szponar, et al.. (2001). [Nocardia and human nocardiosis].. PubMed. 69(11-12). 677–86. 6 indexed citations
19.
Mimoz, Olivier, Anne Jacolot, Nadia Hidri, et al.. (1998). Efficacies of Cefepime, Ceftazidime, and Imipenem Alone or in Combination with Amikacin in Rats with Experimental Pneumonia Due to Ceftazidime-Susceptible or -Resistant Enterobacter cloacae Strains. Antimicrobial Agents and Chemotherapy. 42(12). 3304–3308. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew N. Ginn Breakdown of academic impact, for papers by A. Florijn Breakdown of academic impact, for papers by Tracie Lloyd Breakdown of academic impact, for papers by Annette Jurke Breakdown of academic impact, for papers by Adriana Belas Breakdown of academic impact, for papers by Françoise Chau Breakdown of academic impact, for papers by Najiby Kassis‐Chikhani Breakdown of academic impact, for papers by Dorota Jamrozy Breakdown of academic impact, for papers by Claire Perry Breakdown of academic impact, for papers by Deborah Gascoyne‐Binzi
Rankless by CCL
2026